NHS Grampian conducted a successful trial of a new AI technology called Mia for breast cancer screening, developed by Kheiron Medical Technologies.

Mia detected 12% more tumors than the traditional methods used by radiologists.

The AI technology could decrease radiologists' workload by up to 30%.

Patients with small tumors detected by Mia had a 95% survival rate.

There are limitations to the technology, including the need for diverse training data and machine learning restrictions.

Following the trial's success, there are plans for a larger, nationwide NHS trial to evaluate the integration of AI into routine breast screening services.